Finrozole is an aromatase (CYP19A1) inhibitor.

Finrozole was authorized for veterinary use in the European Union in April 2025.

Medical uses

Finrozole is indicated to shorten the pro-oestrus and oestrus period, reduce clinical signs of heat and reduce the risk of pregnancy.